Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients
D Capodanno, P Capranzano, G Giacchi… - International journal of …, 2013 - Elsevier
Background Warfarin, despite its known limitations, is the reference standard treatment for
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
D Capodanno, P Capranzano, G Giacchi… - International Journal of …, 2013 - infona.pl
Warfarin, despite its known limitations, is the reference standard treatment for patients with
AF and risk factors for stroke. We performed a meta-analysis of phase III trials that compare …
AF and risk factors for stroke. We performed a meta-analysis of phase III trials that compare …
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients.
D Capodanno, P Capranzano, G Giacchi… - … Journal of Cardiology, 2012 - europepmc.org
Background Warfarin, despite its known limitations, is the reference standard treatment for
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients
D Capodanno, P Capranzano… - International …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Warfarin, despite its known limitations, is the reference standard treatment for
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …
[引用][C] Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
D CAPODANNO, P CAPRANZANO… - International journal …, 2013 - pascal-francis.inist.fr
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis
of 50,578 patients CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
of 50,578 patients CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
D Capodanno, P Capranzano… - International …, 2013 - internationaljournalofcardiology.com
Background Warfarin, despite its known limitations, is the reference standard treatment for
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …
patients with AF and risk factors for stroke. We performed a meta-analysis of phase III trials …